Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
about
Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the futureMendelian randomization in cardiometabolic disease: challenges in evaluating causality.Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acidsCommentary: Two-sample Mendelian randomization: opportunities and challengesAtherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study.Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family.Triangulation in aetiological epidemiology.Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge?Recent Developments in Mendelian Randomization Studies.Tripterygium regelii decreases the biosynthesis of triacylglycerol and cholesterol in HepG2 cells.Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies.The druggable genome and support for target identification and validation in drug development.Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke.Metabolic characterization of menopause: cross-sectional and longitudinal evidence.How to use Mendelian randomization to anticipate the results of randomized trials.NAFLD risk alleles in PNPLA3, TM6SF2, GCKR, and LYPLAL1 show divergent metabolic effects.Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataractUse of plasma metabolomics to analyze phenotype-genotype relationships in young hypercholesterolemic females
P2860
Q28074451-E7752A8A-7FE5-4538-B97C-48D01A418BABQ30234302-E2F044D4-80B5-4E65-9F6A-57E9A5BF77A2Q37195954-BA993722-B0FC-429E-BD18-8E1EE7225AF1Q37219780-0E60BFA5-0644-41CC-91D5-9D769C493E4BQ38373507-1D2799F9-DF55-4DBC-9287-C055AE5C0113Q40049090-8268F965-3500-4088-8576-244D4D25A683Q40096191-2591B912-992D-4211-85E2-1D79EF2FBCC9Q40370721-51CBD73C-0D03-4A08-9A9A-33F4BE994ECEQ42372131-2D4FEABE-C718-45CE-9924-AD6CFDE74E31Q47158618-328E70C3-CDC8-4FB6-96E1-54EFE600A9E8Q47579361-4435F593-26FB-4E98-BAFE-F2BDDDE74BC2Q47652764-201E60A3-AC9D-491C-BC22-EE67714F1BE9Q48347170-C24E7953-1BE0-4786-B717-0EE3CBC63A5BQ49695314-081631F3-5FE1-4F26-A4C8-CBB8BB5D83B8Q50062180-F131E961-F460-4A2D-AA16-E3F7E3499CA4Q50094258-C9E9093A-FE0A-4D72-BD91-42F973C4D26CQ52323790-CEDEA4FA-8AB5-4BFC-9E85-F231135BA6D0Q56984696-627B9DDC-39BA-4019-81C9-A1A22A2AED51Q58795927-1D647CC4-B318-4486-A92F-D680747D4627
P2860
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
@ast
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
@en
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
@en-gb
type
label
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
@ast
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
@en
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
@en-gb
prefLabel
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
@ast
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
@en
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
@en-gb
P2093
P2860
P50
P1476
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
@en
P2093
Ghazaleh Fatemifar
Johannes Kettunen
Juan-Pablo Casas
Mauno Vanhala
Mika Tiainen
Nish Chaturvedi
Olli T Raitakari
Pasi Soininen
Peter Würtz
P2860
P304
P356
10.1016/J.JACC.2015.12.060
P407
P50
P577
2016-03-01T00:00:00Z